Iverheal: Effective Parasite Control with Ivermectin Therapy
| Product dosage: 12mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $6.02 | $60.20 (0%) | 🛒 Add to cart |
| 20 | $5.16 | $120.40 $103.20 (14%) | 🛒 Add to cart |
| 30 | $4.87 | $180.60 $146.20 (19%) | 🛒 Add to cart |
| 60 | $4.59 | $361.20 $275.20 (24%) | 🛒 Add to cart |
| 90 | $4.49 | $541.80 $404.20 (25%) | 🛒 Add to cart |
| 120 | $4.44 | $722.40 $533.20 (26%) | 🛒 Add to cart |
| 180 | $4.20
Best per pill | $1083.60 $756.80 (30%) | 🛒 Add to cart |
| Product dosage: 3mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.30 | $43.00 (0%) | 🛒 Add to cart |
| 20 | $3.44 | $86.00 $68.80 (20%) | 🛒 Add to cart |
| 30 | $3.15 | $129.00 $94.60 (27%) | 🛒 Add to cart |
| 60 | $2.87 | $258.00 $172.00 (33%) | 🛒 Add to cart |
| 90 | $2.68 | $387.00 $240.80 (38%) | 🛒 Add to cart |
| 120 | $2.51 | $516.00 $301.00 (42%) | 🛒 Add to cart |
| 180 | $2.39 | $774.00 $430.00 (44%) | 🛒 Add to cart |
| 270 | $2.26
Best per pill | $1161.00 $610.60 (47%) | 🛒 Add to cart |
| Product dosage: 6mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.16 | $51.60 (0%) | 🛒 Add to cart |
| 20 | $4.30 | $103.20 $86.00 (17%) | 🛒 Add to cart |
| 30 | $3.73 | $154.80 $111.80 (28%) | 🛒 Add to cart |
| 60 | $3.44 | $309.60 $206.40 (33%) | 🛒 Add to cart |
| 90 | $3.25 | $464.40 $292.40 (37%) | 🛒 Add to cart |
| 120 | $3.01 | $619.20 $361.20 (42%) | 🛒 Add to cart |
| 180 | $2.87 | $928.80 $516.00 (44%) | 🛒 Add to cart |
| 270 | $2.68
Best per pill | $1393.20 $722.40 (48%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Iverheal is a prescription medication containing ivermectin, an antiparasitic agent recognized for its broad-spectrum efficacy against a range of parasitic infestations. It works by binding to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to increased cell permeability, paralysis, and death of the parasites. This mechanism provides a targeted approach to eliminating both internal and external parasites, offering a critical tool in clinical and public health settings. Proper diagnosis and medical supervision are essential for its safe and effective use.
Features
- Active ingredient: Ivermectin
- Available in tablet formulations (common strengths: 3 mg, 6 mg, 12 mg)
- High bioavailability when administered orally
- Exhibits activity against a broad spectrum of nematodes and ectoparasites
- Manufactured under strict pharmaceutical quality control standards
Benefits
- Effectively eliminates target parasites, resolving associated infections
- Reduces transmission of parasitic diseases in endemic communities
- Contributes to improved nutritional status and overall health by clearing debilitating infestations
- Supports mass drug administration programs for disease control
- Single-dose regimens are effective for several indications, supporting patient compliance
- Helps alleviate symptoms such as pruritus, skin lesions, and visual impairment linked to certain parasitic diseases
Common use
Iverheal (ivermectin) is primarily indicated for the treatment of parasitic worm infections. Its most prominent use is in the management of strongyloidiasis, an intestinal infection caused by the nematode Strongyloides stercoralis, and onchocerciasis (river blindness), caused by the filarial worm Onchocerca volvulus. It is also employed in the treatment of scabies, particularly crusted scabies, often in combination with topical agents. In certain public health initiatives, it is used in mass drug administration programs for the control of lymphatic filariasis in combination with other antiparasitic agents, in regions where these diseases are endemic. Off-label uses may include treatment for other ectoparasitic infestations, such as head lice, though such use should be guided by a healthcare professional based on individual assessment.
Dosage and direction
Dosage of Iverheal is strictly based on body weight and the specific parasitic infection being treated, and must be determined by a qualified healthcare provider. It is typically administered orally as a single dose on an empty stomach with a full glass of water to maximize absorption.
- For strongyloidiasis: The standard dose is 200 mcg per kilogram of body weight.
- For onchocerciasis: The standard dose is 150 mcg per kilogram of body weight; treatment may be repeated every 6 to 12 months as required, depending on symptoms and exposure.
- For scabies: Although not always first-line, doses may range, with some protocols using 200 mcg/kg, repeated after 1-2 weeks in certain cases.
It is crucial to follow the prescribed schedule exactly. Do not crush or chew the tablet; swallow it whole. Adherence to the treatment regimen is vital for efficacy and to minimize the risk of resistance.
Precautions
Before taking Iverheal, discuss your full medical history with your doctor, including any liver conditions, as hepatic impairment may affect drug metabolism. Inform your physician if you are pregnant, planning to become pregnant, or breastfeeding, as the risks and benefits must be carefully evaluated—ivermectin is not typically recommended during pregnancy unless the potential benefit justifies the potential risk. Use with caution in elderly patients or those with severe chronic illnesses. Since ivermectin can cause dizziness or drowsiness in some individuals, avoid driving or operating heavy machinery until you know how the medication affects you. Ensure adequate hydration unless advised otherwise by your doctor.
Contraindications
Iverheal is contraindicated in patients with a known hypersensitivity to ivermectin or any other component of the formulation. It should not be used in conjunction with other medications that increase permeability of the blood-brain barrier (e.g., certain immunosuppressants) without extreme caution and specialist oversight, due to the increased risk of neurotoxicity. Use is generally avoided during pregnancy, especially in the first trimester, unless no alternatives are available and the infection poses a significant risk. Its safety in infants weighing less than 15 kg has not been firmly established for all indications.
Possible side effect
While generally well-tolerated when used as prescribed, some patients may experience side effects. Most are mild and transient.
Common side effects may include:
- Dizziness, lightheadedness
- Nausea, diarrhea, or loss of appetite
- Pruritus (itching), rash, or mild skin reactions
- Fatigue or drowsiness
Less common but more serious side effects require immediate medical attention:
- Severe skin reactions (e.g., Stevens-Johnson syndrome)
- Worsening asthma or difficulty breathing
- Fast heart rate, fever, or swelling of the face/eyes/lips/tongue (signs of a severe allergic reaction)
- Visual changes, eye pain, or redness (particularly in patients with high Loa loa microfilarial loads, due to the risk of encephalopathy)
- Worsening weakness or confusion
The Mazzotti reaction (fever, rash, arthralgia, lymphadenopathy) is a known inflammatory response in patients with onchocerciasis following treatment, due to the death of microfilariae.
Drug interaction
Iverheal can interact with other medications, potentially altering their effects or increasing the risk of adverse reactions.
- CNS Depressants: Concomitant use with alcohol, benzodiazepines, barbiturates, or opioids may enhance sedative effects.
- Warfarin and Other Anticoagulants: Ivermectin may potentially potentiate anticoagulant effects; close monitoring of INR is advised.
- Certain Anticonvulsants (e.g., valproic acid) and Antimicrobials: May compete for metabolic pathways, though clinical significance is variable.
- Drugs that Inhibit P-glycoprotein (e.g., cyclosporine, quinidine): May increase ivermectin plasma concentrations, raising the risk of neurotoxicity.
Always provide your doctor with a complete list of all medications you are taking, including prescription drugs, over-the-counter products, and herbal supplements.
Missed dose
Since Iverheal is often administered as a single dose or on a specific schedule for repeat dosing, the concept of a “missed dose” may not always apply in the same way as with daily medications. If a dose is missed and you are on a multi-dose regimen, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up. For single-dose regimens, contact your healthcare provider for advice if you vomit shortly after taking the tablet or fail to take it as scheduled.
Overdose
Overdose of ivermectin can be dangerous and may intensify its known adverse effects. Symptoms of overdose may include severe nausea, vomiting, diarrhea, dizziness, sedation, confusion, hypotension, respiratory depression, and in extreme cases, seizures or coma. In the event of a suspected overdose, seek emergency medical attention immediately. Provide medical personnel with the medication packaging and details of the amount ingested. Treatment is supportive and may include gastric lavage (if ingestion was recent) and management of specific symptoms; there is no specific antidote.
Storage
Store Iverheal tablets at room temperature (between 15°C and 30°C), in a dry place, protected from light and moisture. Keep the medication in its original blister pack or container until use to protect it from degradation. Always keep all medicines out of the reach of children and pets to prevent accidental ingestion. Do not use tablets that are discolored, cracked, or beyond their expiration date. Proper disposal of unused medication is important; consult your pharmacist for local disposal guidelines—do not flush down the toilet or pour into drains.
Disclaimer
This information is intended for educational purposes only and does not constitute medical advice. It is not a substitute for professional medical diagnosis, treatment, or guidance. Always consult a qualified healthcare provider before starting, stopping, or changing any medical treatment. Do not use this information to self-diagnose or self-treat a health problem. The efficacy and safety profile described may vary based on individual patient factors, local prevalence of parasites, and emerging clinical evidence. The manufacturer and author disclaim any liability for any adverse effects resulting from the use or application of the information contained herein.
Reviews
Clinical and patient feedback for Iverheal often highlights its efficacy in resolving stubborn parasitic infections when used appropriately.
- Dr. Elena R., Infectious Disease Specialist: “In our practice, ivermectin remains a cornerstone for managing strongyloidiasis and in our onchocerciasis control programs. Its impact on reducing microfilarial loads and associated morbidity is well-documented. We always emphasize the need for precise weight-based dosing and monitoring in co-endemic areas for Loa loa.”
- Public Health Coordinator, West Africa: “The use of ivermectin in mass drug administration has been transformative for communities burdened by river blindness. The single-dose regimen supports high coverage and compliance, making large-scale control feasible.”
- Patient with chronic strongyloidiasis: “After struggling with digestive issues for years, a single course of Iverheal prescribed by my doctor finally cleared the infection. The treatment was straightforward, and I experienced only mild dizziness the next day.”
- Dermatologist’s note on scabies: “For cases of conventional scabies unresponsive to topical permethrin, or in institutional outbreaks, oral ivermectin provides a valuable alternative. We typically see rapid improvement in itching and skin lesions within days.”